Commonwealth Equity Services’s Evogene EVGN Stock Holding History

Commonwealth Equity Services’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,109	Closed	-$8K	–	4086
2024 Q1	$8K	Buy	+1,109	New	+$9.25K	﹤0.01%	4001
2023 Q4	–	Sell	-1,136	Closed	-$7K	–	3940
2023 Q3	$7K	Hold	1,136	–	–	﹤0.01%	3791
2023 Q2	$12K	Hold	1,136	–	–	﹤0.01%	3776
2023 Q1	$7	Hold	1,136	–	–	﹤0.01%	3735
2022 Q4	$7K	Sell	1,136 -538	-32%	-$3.79K	﹤0.01%	3667
2022 Q3	$13K	Buy	1,674 +152	+10%	+$1.47K	﹤0.01%	3606
2022 Q2	$11K	Buy	1,522 +50	+3%	+$489	﹤0.01%	3616
2022 Q1	$19K	Sell	1,472 -50	-3%	-$674	﹤0.01%	3662
2021 Q4	$24K	Buy	1,522 +112	+8%	+$2.54K	﹤0.01%	3591
2021 Q3	$37K	Sell	1,410 -62	-4%	-$1.81K	﹤0.01%	3514
2021 Q2	$50K	Buy	1,472 +30	+2%	+$1.18K	﹤0.01%	3459
2021 Q1	$72K	Sell	1,442 -621	-30%	-$38.4K	﹤0.01%	3308
2020 Q4	$96K	Buy	+2,063	New	+$72.7K	﹤0.01%	3067

Other funds holding EVGN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JIC

Joel Isaacson & Co New York $3.02B AUM 21.81% 1-Year Est. Return

Commonwealth Equity Services's EVGN Position: Q2 2024 in Review

Commonwealth Equity Services sold out of Evogene (EVGN) in Q2 2024, closing a stake of 1,109 shares — an estimated $8K sold.

Commonwealth Equity Services first reported a position in EVGN in Q4 2020 and held it in 13 quarters. The position peaked at $96K in Q4 2020. 28 funds tracked by Wall St. Rank hold EVGN as of Q2 2024.

Commonwealth Equity Services reported no remaining Evogene position as of Q2 2024 after selling out during the quarter.
Commonwealth Equity Services sold 1,109 Evogene shares in Q2 2024, an estimated $8K.
Commonwealth Equity Services first reported a position in Evogene in Q4 2020 and held it in 13 quarters.
Commonwealth Equity Services's Evogene position peaked at $96K in Q4 2020.
28 funds tracked by Wall St. Rank held Evogene as of Q2 2024.

Based on Commonwealth Equity Services's 13F filing for Q2 2024, filed 31 Jul 2024.